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esponsibility of Xi'aAbstract The present study reports voltammetric reduction of nitazoxanide in Britton–Robinson (B–R)
buffer by cyclic and square-wave voltammetry at glassy carbon electrode. A versatile fully validated
voltammetric method for quantitative determination of nitazoxanide in pharmaceutical formulation has
been proposed. A squrewave peak current was linear over the nitazoxanide concentration in the range of
20–140 mg/mL. The limit of detection (LOD) and limit of quantiﬁcation (LOQ) was calculated to be
5.23 μg/mL and 17.45 μg/mL, respectively.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Intestinal parasitic infections rank among the most signiﬁcant
causes of morbidity and mortality in the world today. Nitazoxanide
(Scheme 1) is a new nitrothiazole benzamide compound notable
for its activity in treating both intestinal protozoal and helminthic
infections [1]. Nitazoxanide in humans has been reported to be
effective against a broad range of parasites, including Giardia
lamblia, Entamoeba histolytica and Cryptosporidium parvum [2].
Literature survey reveals few analytical methods including high-
performance liquid chromatography (HPLC) [3], spectrophotometry
[4], stability indicating high performance thin layer chromatographysity. Production and hosting by Else
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n Jiaotong University.(HPTLC) [5] and colorimetric method [6] for the quantiﬁcation of
nitazoxanide. These methods are time consuming and require large
number of complicated steps to follow on for analysis. For this purpose
the desirable technique for the analysis of drugs should be rapid,
simple, low cost and of high sensitivity in analysis. Therefore, in order
to have better technique for analysis of drugs electrochemical methods
have been applied [7,8]. There are already reported electrochemical
methods for the analysis of the nitazoxanide [9–12], these methods
show low sensitivity compared to proposed voltammetric method for
the detection of nitazoxanide. The purpose of the present work is to
study the voltammetric behavior of nitazoxanide by employing cyclic
and squarewave voltammetry and to establish the methodology for the
determination of nitazoxanide in pharmaceutical formulation.
2. Experimental
2.1. Instrumentation
Electrochemical measurements were performed using a
m-Autolab type III (Eco-Chemie B.V., Utrecht, The Netherlands)
potentiostat–galvanostat with 757 VA computrace software. Thevier B.V. All rights reserved.
Scheme 1 Structure of nitazoxanide.
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Ag/AgCl (3 M KCl) as reference electrode and platinum wire as
auxiliary electrode. The electrochemical cell was a Metrohm 663
VA stand (Metrohm AG, The Netherlands). Controlled potential
coulometric experiments were carried out using an Autolab
Potentiostat/Galvanostat PGSTAT Metrohm 663 VA stand as
electrochemical cell, ﬁtted with a PC provided with the appropriate
GPES 4.2 software. All the solutions examined by electrochemical
technique were purged for 10 min with puriﬁed nitrogen gas. All
pH-metric measurements were made on a Decible DB-1011 digital
pH meter ﬁtted with a glass electrode and a saturated calomel
electrode as reference, which was previously standardized with
buffers of known pH.
2.2. Reagents and materials
Nitazoxanide (99% purity) was obtained from Alembic limited
India and used as received. Capsules containing nitazoxanide
(Nitacure) labeled 500 mg were obtained from commercial
sources. The solvents (1,4 dioxane, dimethyl formamide (DMF),
acetonitrile (ACN) and ethanol) and surfactants (cetrimide and
tween-20) were purchased from Sigma-Aldrich, India. Britton–
Robinson (B–R) supporting buffers of different pH values were
prepared by dissolving appropriate volumes of boric acid and
glacial acetic acid in distilled water.
2.3. Procedure for pharmaceutical preparation
The contents of 10 capsules were weighed and powdered in
a mortar. A weighed portion of the powder was transferred to
a 250 mL volumetric ﬂask containing dioxane to form a stock
solution of 1 mg/mL and then ﬂask was put in ultrasonic bath for
5 min. A portion of this solution was centrifuged and the super-
natant was ﬁltered through a ﬁlter paper and ﬁltered solution was
then transferred to the voltammetric cell and voltammograms were
recorded. Potassium chloride (1.0 M) solution was prepared in
distilled water and used as supporting electrolyte. The content of
the drug in pharmaceutical formulation was determined using
calibration curve.
2.4. Pretreatment of glassy carbon electrode
Before each measurement, the glassy carbon electrode (GCE) was
polished on a polishing micro-cloth with 0.5 mM alumina powder
and rinsed thoroughly with redistilled water, followed by sonica-
tion for 5 min in an ultrasonic bath. The electrode was then
transferred to the supporting electrolyte and potential in the
range from 0.1 to 1.6 V was applied in a regime of cyclic
voltammetry for 20 cycles until a stable voltammograms was
achieved.3. Results and discussion
3.1. Optimization of the experimental conditions
Square-wave voltammetry was used to optimize a rapid and
sensitive electroanalytical procedure for the determination of
nitazoxanide in a pharmaceutical dosage form. The square-wave
voltammetric response depends markedly on instrumental para-
meters. To obtain a high sensitivity (peak current), the optimum
instrumental parameters, viz., pulse amplitude and frequency, were
studied for 20 mg/mL nitazoxanide solution. The frequency is
varied from 50 to 140 Hz. Although the response to nitazoxanide
increased with frequency up to 70 Hz after that the peak current
was masked by a large residual current. When the pulse amplitude
was varied in the range of 10–100 mV, the peak current increased
with increasing pulse amplitude. Analysis of the data showed a
linear increase in the peak height for amplitudes ESWr50 mV.
When the pulse amplitude was greater than 50 mV, the peak width
increased at the same time. Hence, the best peak was obtained
when 70 Hz square-wave frequency, 50 mV pulse amplitude and
10 mV scan rate were employed.3.2. Effect of pH
The pH effect on the peak current of 100 μg/mL nitazoxanide was
studied in B–R buffer in the pH range from 2.0 to 11.0. A well-
deﬁned cathodic peak was obtained at pH 3.0 and hence this pH
was taken as optimum for complete investigation. The cathodic
peak shifted towards more negative potential with increase in pH
indicates participation of proton in the electrode process.3.3. Effect of different solvents
The effect of different solvent systems viz., dimethyl formamide,
1,4 dioxane, acetonitrile, ethanol and surfactants (cetrimide and
tween-20) on the reduction of nitazoxanide was investigated by the
proposed voltammetric procedure. On comparing the voltammetric
behavior of nitazoxanide in different solvent systems, it was
observed that nitazoxanide showed substantial increase in peak
current and the limit of detection (LOD) was found to be lower in
1,4 dioxane. While in other organic solvents nitazoxanide
adsorbed at the electrode surface to varying degrees and hence
hampered the kinetics of redox process at the electrode surface.
Thus 1,4 dioxane was selected for the analysis of nitazoxanide by
the proposed voltammetric procedure.3.4. Cyclic voltammetric behavior
Cyclic voltammograms (Fig. 1) of nitazoxanide yield single well-
deﬁned reduction peak at 0.75 V in B–R buffer at pH 3.0 and no
oxidation peak was observed in reverse scan, indicating the
irreversibility of the electrode process. The effect of the scan
rate (v) on the peak current (Ip) was studied in the range of
50–250 mV/s. A linear plot was obtained between the log Ip and
log ν expressed by the equation: log Ip¼0.4937ν (mV/s)+0.8536
(r2¼0.984), a slope of 0.49 obtained is close to the 0.5 which
reﬂects that reduction process is diffusion controlled [13].
Fig. 1 Cyclic voltammograms of 100 μg/mL nitazoxanide in dioxane
at different scan rates; 50, 100,150, 200, and 250 mV/s.
R-NO2+ 2e-+ 4H+  R-NHOH+ H2O 
Scheme 2 Reduction of nitazoxanide.
R. Jain et al.4543.5. Validation of the proposed method
The analytical method was validated with respect to parameters
such as LOD, LOQ, speciﬁcity, precision and accuracy [14].3.5.1. LOD
The LOD is calculated by the equation LOD¼3(SD/b), where SD
is the standard deviation of the intercept and b is the average slope
of the regression line. The calculated LOD for the standard
solution was 5.23 μg/mL.3.5.2. LOQ
The LOQ is examined by the equation LOQ¼10(SD/b). The LOQ
for the standard solution was found to be 17.45 μg/mL.3.5.3. Speciﬁcity
Speciﬁcity is the ability of method to measure analytical response in
the presence of all potential ingredients present in pharmaceutical
formulation. For speciﬁcity test, voltammograms of standard solution
containing excipients (starch, gelatin, lactose, and magnesium stea-
rate) were recorded under selected conditions. Response of analyte in
this mixture was compared with the response of pure nitazoxanide. It
was found that assay results were not affected by the presence of
excipients in pharmaceutical formulation.3.5.4. Accuracy and precision
The accuracy of a method is the degree of the nearness of the real
value to observed analysis results. The accuracy of the analysis
was determined by calculating the percentage relative error
between the measured mean concentration and the nominal
concentration. Precision is expressed in terms of the relative
standard deviation. The values of both accuracy and precision
were found to be less than 5%, indicating the high precision and
accuracy of the method and the conﬁdence in its repeatability [15].3.6. Analytical application
To check the applicability of the proposed method, a commercial
tablet formulation containing nitazoxanide was analyzed. Because
of high concentration of nitazoxanide in its dosage form no
accumulation time was needed and tablet assay was conducted
using the square-wave voltammetry. The variation of the peak
current with the nitazoxanide concentration was investigated by
recording square-wave voltammograms at different concentrations
of nitazoxanide. The relationship between peak current and
concentration was found to be linear over the range of
20–140 mg/mL. Linear equation is expressed as Ip (mA)¼ (0.0871)
Cnitazoxanide (mg/mL)+0.4371, r
2¼0.9938, where Ip is the peak
current in μA, C is the concentration in mg/mL and r is the
correlation coefﬁcient.
3.7. Controlled potential electrolysis and reaction mechanism
By using controlled potential coulometry, the number of electrons
n transferred was calculated from the charge consumed by the
desired concentration of nitazoxanide. The charge consumed was
determined in acidic medium. For this purpose 2 mL of 5 mg/mL
solution of the electroactive species was placed in the cell and
electrolysis was carried out at a potential of 0.75 V against
Ag/AgCl reference electrode. During the electrolysis, solutions
were continuously stirred and purged with nitrogen. Number of
electrons n was calculated using the equation Q¼nFN, where Q is
the charge in coulombs, F is the Faradays constant and N is the
number of moles of the substrate. The calculated number of
electrons is found to be two for the cathodic peak of nitazoxanide.
On the basis of cyclic voltammetry, squarewave voltammetry
and coulometric studies, the following mechanism has been
postulated for the reduction of nitazoxanide in acidic conditions
(Scheme 2).
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